Reaction Biology Corp. Awarded NIH R01 Screening Roadmap Grant for Microarray Screening Development
freeNewsArticles Story Summary: MALVERN, PA – Mar. 13 (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (‘RBC’) today announced that it has been awarded an R01 grant from the National Institutes of Health to accelerate development of its new DiscoveryDot(TM) High Throughput Screening technology for drug discovery. The NIH grant is part of the Screening Roadmap, designed to produce innovative chemical tools for use in biological research and drug development. Out of 8 recipients of grants pursuant to the original RFA, Reaction Biology is the only private corporation to be so awarded.